Penn Medicine Princeton Medical Center

More Aggressive Treatment Doesn't Impact Quality of Life for Metastatic Colorectal Cancer Patients, According to New Study in JNCCN

Retrieved on: 
Thursday, October 12, 2023
Neoplasm, Quality of life, CAPOX, Max Healthcare, Penn Medicine Princeton Medical Center, Bevacizumab, Risk, Radiation, EORTC, SAE, Șaeș, Survival, Outline of health sciences, University, Disease, FOLFOX, Patient, Quality of life (healthcare), FACP, University of Pennsylvania Health System, Fatigue, Medicine, Journal of the National Comprehensive Cancer Network, National Comprehensive Cancer Network, Overalls, Face, Perelman Center for Advanced Medicine, Research, Pharmaceutical industry, Nursing, Medical imaging, Life, MD

PLYMOUTH MEETING, Pa., Oct. 12, 2023 /PRNewswire/ -- New research in the October 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network finds that intensive local-regional treatment to remove as much tumor as possible (known as "debulking"), in addition to standard systemic therapy, does not impact overall quality of life significantly for people with metastatic colorectal cancer.

Key Points: 
  • Significant adverse events were reported in 21% of patients in the standard group and 43% of patients who also received tumor debulking.
  • However, there were no statistical or clinically relevant differences according to patient-reported outcomes for overall health-related quality of life or fatigue.
  • "This could mean that the negative impact of complications on quality of life is temporary and eventually balances out with a decrease in tumor-related symptoms after treatment.
  • "Given the considerable amount of complications from local treatment, we had expected to see a bigger impact on overall and persistent quality of life in the experimental group.

PENN MEDICINE TO STOP ACTIVELY PARTICIPATING IN U.S. NEWS & WORLD REPORT "BEST HOSPITALS" RANKINGS

Retrieved on: 
Monday, June 26, 2023
Vaccine, American Hospital Association, Infection, Medical school, Telehealth, University of Pennsylvania Health System, Perelman School of Medicine at the University of Pennsylvania, Hospital of the University of Pennsylvania, University, Education, Centers for Medicare & Medicaid Services, AUC, U.S. News & World Report Best Hospitals Rankings, Hospital, COVID-19, Raymond, Cancer, Biomedical Research, Roll, Research, Medicine, We, Element, Penn Medicine Princeton Medical Center, Penn, U.S. News & World Report, Penn Presbyterian Medical Center, Bangladesh Technical Education Board, Messenger, Medicare, CAR, NYU Annual Survey of American Law, Home, Patient, Susquehanna River, Faculty, Penns, Health, News, Pharmaceutical industry, Pennsylvania Hospital, MD

Modern medicine goes far beyond hospital walls. Today's health systems provide primary care along with advanced care--from surgeries to cancer treatment to kidney dialysis--in outpatient facilities, in patients' homes, and through virtual platforms or remote monitoring. Although the Hospitals of the University of Pennsylvania-Penn Presbyterian has been named to the "Best Hospitals" Honor Roll of top 20 hospitals for the past 16 consecutive years and Penn Medicine's regional hospitals are ranked among the best in the health system's service area, its leaders say the rankings represent an outdated view of health care, failing to capture the full breadth of "care everywhere" services.

Key Points: 
  • The U.S. News & World Report "Best Hospitals" rankings are based solely on inpatient hospital care of those insured by Medicare.
  • While U.S. News & World Report may continue to rank Penn Medicine hospitals, the health system will cease active participation in the process or results.
  • Penn Medicine will also discontinue any promotion of its position on the "Honor Roll," specialty rankings, or any other rankings content, and it will stop purchasing the U.S. News & World Report badges required to publicize the rankings.
  • Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.

Independence Blue Cross Launches Advanced Network for Gene-Based Therapeutics

Retrieved on: 
Thursday, January 26, 2023
Safety, Therapy, Independence Blue Cross, DSM-IV codes, University of Pennsylvania Health System, Health marketing, Diagnosis, Advanced Network and Services, Transplant, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Partnership, Penn Medicine Princeton Medical Center, CHOP, Hospital, Cell therapy, Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Paratriathlon, Health care, Perelman Center for Advanced Medicine, Patient, Quality of life, Food, Pharmaceutical industry, Nursing, Independence

PHILADELPHIA, Jan. 26, 2023 /PRNewswire/ -- Independence Blue Cross (Independence) today announced the launch of its Advanced Network for Gene-Based Therapeutics, which will be effective March 1, 2023. The new network is designed to help members access potentially life-changing gene-based therapies from best-in-class health care providers that have demonstrated an ability to exceed quality, safety, and value benchmarks in administering gene-based therapies. These treatments provide fresh hope for patients with inherited rare genetic conditions, including a form of blindness and severe neurological and blood diseases.

Key Points: 
  • PHILADELPHIA, Jan. 26, 2023 /PRNewswire/ -- Independence Blue Cross (Independence) today announced the launch of its Advanced Network for Gene-Based Therapeutics, which will be effective March 1, 2023.
  • The providers in Independence's Advanced Network for Gene-Based Therapeutics include Penn Medicine and Children's Hospital of Philadelphia (CHOP).
  • We look forward to continuing this collaboration and leading the way in providing the best possible treatments for children with genetic diseases as part of the Advanced Network for Gene-Based Therapeutics."
  • The dedicated team is trained to answer member questions, empower member decision-making, and facilitate connections between members and the specialists on the Advanced Network care team.

Penn Medicine, Independence Blue Cross, and Tandigm Health Partner to Expand Value-Based Care

Retrieved on: 
Tuesday, September 27, 2022
Adoption, Center, Medicare, Sale, Population Health Management, Organization, University of Pennsylvania Health System, Independence Blue Cross, Penn Medicine Princeton Medical Center, Diabetes, Patient, Medicare Advantage, Physician, CEO, Centers for Medicare & Medicaid Services, University, Conditional sentence, Hospital, Pharmaceutical industry, Health insurance, Humana, Independence

PHILADELPHIA, Sept. 27, 2022 /PRNewswire/ -- Independence Blue Cross (Independence) and Penn Medicine today announce a plan to deepen their longstanding collaborations to transform healthcare in the Philadelphia region. The centerpiece of this expanding relationship is Independence's sale of a minority equity stake in its subsidiary, Tandigm Health, to Penn Medicine, which will allow more patients to continue seeing their trusted primary care providers close to home while offering new, innovative pathways to Penn Medicine's specialty care and other services. Together, the organizations will join forces in new ways to improve patient outcomes and drive more cost-efficient care, while also increasing provider satisfaction.

Key Points: 
  • The agreement, which officially launches on January 1, 2023, also contains a long-term commitment from Penn Medicine to work with Tandigm for all primary care value-based programs across all payors.
  • Independence and Penn Medicine have collaborated extensively to accelerate the adoption of value-based care.
  • "Tandigm is honored to earn the trust of Independence, Penn Medicine, and the Tandigm network of outstanding physicians," said Frank Ingari, CEO of Tandigm.
  • Moving forward in the new arrangement, Tandigm primary care providers may be able to expand their impact through facilitated access to Penn Medicine resources such as specialty care, advanced home care services, and virtual off-hours coverage for patients in need outside of office hours.

Playground Launches Sex and Wellness Council and Names Dr. Emily Morse as Chief Sexologist

Retrieved on: 
Wednesday, September 21, 2022
Lives, Sex, Woman, Lubricant, NAMS, Entrepreneurship, Industry, Human sexuality, Carrie Bradshaw, CEO, Instagram, Embarrassment, Board, SAN, Health minister, Research, ITunes, Human, Chief Medical Advisor to the President, Pleasure, Multimedia, Penn Medicine Princeton Medical Center, Birth control, Psyche

SAN FRANCISCO, Sept. 21, 2022 /PRNewswire/ -- Today Playground, a new sexual wellness brand that champions women to celebrate their sexuality, introduces its Sex and Wellness Council. Led by Chief Sexologist Emily Morse, the council's mission is to support and encourage women to embrace sexual health as an essential part of their overall wellness through educational conversations guided by leading industry experts. 

Key Points: 
  • SAN FRANCISCO, Sept. 21, 2022 /PRNewswire/ -- Today Playground , a new sexual wellness brand that champions women to celebrate their sexuality, introduces its Sex and Wellness Council.
  • Widely considered the leading sex expert, Doctor of Human Sexuality, Emily Morse brings a Carrie Bradshaw meets Bren Brown approach to sex as host of the #1 sexuality podcast on iTunes, Sex with Emily .
  • As Playground's Chief Sexologist, Morse will continue to advance these important discussions in the industry.
  • As part of the launch, the Sex and Wellness Council introduces Sex and the Psyche , a guide to sex, intimacy, and sexual health where council members will address vital questions and trending topics.

Rocket VR Health Partners with Penn Medicine's Abramson Cancer Center to Study the Use of VR in Patients Undergoing Radiation Therapy

Retrieved on: 
Thursday, August 18, 2022
Meditation, Multimedia, Lists of Palestinian rocket attacks on Israel, Mental health, HTC, Penn, Technology, Cancer, Radiation therapy, Department, Health, Virtual reality, Patient, Perelman School of Medicine at the University of Pennsylvania, View, Therapy, Perelman Center for Advanced Medicine, COO, Nature, Mindfulness, Survivor, Penn Medicine Princeton Medical Center, MD, VR, University of Pennsylvania Health System, Medical imaging

BOSTON, Aug. 18, 2022 /PRNewswire/ -- Rocket VR Health, a digital therapeutics company developing immersive therapy programs, is partnering with Penn Medicine's Abramson Cancer Center to explore the use of virtual reality (VR) technology in cancer patients undergoing radiation therapy.

Key Points: 
  • BOSTON, Aug. 18, 2022 /PRNewswire/ -- Rocket VR Health , a digital therapeutics company developing immersive therapy programs, is partnering with Penn Medicine's Abramson Cancer Center to explore the use of virtual reality (VR) technology in cancer patients undergoing radiation therapy.
  • Rocket VR's immersive meditation program will be administered as part of a feasibility study with 25 patients prior to receiving daily treatments, utilizing the HTC VIVE Flow VR headset.
  • The imagery and sounds experienced are designed to create an immersive environment by making use of mindfulness meditation in nature.
  • Rocket VR Health is developing virtual reality digital therapeutics to address unmet mental health needs in cancer patients and survivors.

Tribeca Film Festival to Debut Documentary Tracing the Path to Penn Medicine and Children's Hospital of Philadelphia's Transformative, Personalized Cancer Therapy

Retrieved on: 
Thursday, June 9, 2022
Cell therapy, Doctor of Philosophy, Trauma, Perelman School of Medicine at the University of Pennsylvania, Workforce, Transplant, University of Pennsylvania Health System, Family, Cancer, Tribeca Film Festival, U.S. News & World Report Best Hospitals Rankings, Biomedical Research, Therapy, Child, News, Perelman Center for Advanced Medicine, CAR, Center, Children's Hospital of Philadelphia, National, Health, MD, Academic health science centre, Honors student, Penn Medicine Princeton Medical Center, Inauguration, School, University, Patient, Section, Hospital, Raymond, Leukemia, CHOP, Life, Research, Barbara, Medical school, Home, Oscar, Clinical trial, Hospital of the University of Pennsylvania, Entertainment, Veterinary medicine, Upworthy, Medicine, Immunotherapy, Pennsylvania Hospital

PHILADELPHIA, June 9, 2022 /PRNewswire/ -- The behind-the-scenes story detailing the pursuit of a transformative cancer cure will unfold onscreen at the Tribeca Film Festival in New York City this weekend. "Of Medicine and Miracles," which will premiere during the renowned international festival, is an emotional journey, revealing decades of research – and one young patient's family's last hopes to save their daughter – that culminated in the world's first CAR T-cell therapy, an approach that reprograms patients' own immune cells to kill their cancer.

Key Points: 
  • News & World ReportChester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; and Pennsylvania Hospital, the nation's first hospital, founded in 1751.
  • Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
  • About Children's Hospital of Philadelphia:
    A non-profit, charitable organization, Children's Hospital ofPhiladelphiawas founded in 1855 as the nation's first pediatric hospital.
  • In addition, its unique family-centered care and public service programs have brought Children's Hospital ofPhiladelphiarecognition as a leading advocate for children and adolescents.